Sicriptin 2.5 Tablet (Bromocriptine 2.5mg)

Sicriptin 2.5 Tablet

Sicriptin 2.5Mg Tablet is used in the treatment of Parkinson’s disease. It can control symptoms of hyperprolactinemia including excess production of breastmilk, hypogonadism, infertility and a number of disruptions in the menstrual cycle. The drug helps to control the abnormally high production of growth hormones, and can inhibit the growth of certain tumours that release excess amounts of prolactin.

Sicriptin 2.5Mg Tablet has strong dopaminergic effects and works by activating dopamine D2 receptors and also as a partial agonist of D1 receptors. Postsynaptic activation of D2 receptors lead to antiparkinson effects whereas presynaptic activation of D2 receptors lead to neuroprotective effects. Activation of D2 receptors in the nigrostriatal pathway is responsible for improving coordinated muscle movements in people with Parkinson’s. Sicriptin 2.5Mg Tablet also has prolactin inhibitory effect by inhibiting lactotrophic cells in the anterior pituitary from secreting prolactin due to increased production of dopamine.

Sicriptin 2.5Mg Tablet may cause some side effects including nausea, light-headedness, dizziness, drowsiness, vomiting, irregular heartbeat, hypotension, vasospasms, insomnia, depression and fatigue. Consult your doctor immediately if you experience any of the more serious side effects like fainting, hallucinations, mental or mood changes like anxiety, paranoia, or confusion, swollen feet or ankles, vomit containing blood or particles which look like coffee grounds, impaired vision, chest pain, abnormal coloured stool, breathing problems, numbness on one side of body and a persistent runny nose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

Use

Female Infertility

Type 2 Diabetes

Acromegaly

Related Product

Side Effects

Nausea

Vomiting

Headache

Dizziness

Fatigue

Work

The active constituent of this medication is an ergot derivative that works as a dopamine D2 agonist. It exhibits antiparkinson and lactation inhibiting effect by selectively binding to dopamine D2 receptors in the CNS. This inhibits adenylyl cyclase which prevents signal transduction mediated via cAMP and results in an inhibition of neurotransmission.